CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11, ...

CRISPR has turned a simple fungus into a fast-growing, meat-like protein source with impressively low environmental impact.

A quiet hope has started to grow among people living with stubborn cholesterol problems as researchers report early success ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...

The patient who was hospitalized after receiving Intellia Therapeutics’ CRISPR therapy nex-z has died. | The patient who was ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Outcomes validate the company’s PTAP platform as a foundation for a rapid, adaptable antiviral modality across animal and ...

Launching the therapy, Dr. Jitendra Singh declared that India has officially begun its decisive march toward a Sickle ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...